Save time and jump to the most important pieces.
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - March 27, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") is pleased to announce its financial and operating results for the year ended December 31, 2022. Alpine Summit's audited consolidated financial statements and notes, as well as management's discussion and analysis (the "MD&A") and its Annual Report on Form 10-K for the year ended December 31, 2022 will be available under the Company's issuer profile at "www.sedar.com" and "www.sec.gov/edgar", as well as on the Company's website at "www.alpinesummitenergy.com".Craig Perry, Chief Executive Officer, remarked:
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that the Board of Directors is commencing a strategic review of its assets. The Company seeks to facilitate a timely and orderly response to unsolicited inquiries by other upstream oil and gas companies who have expressed interest in acquiring various assets of the Company. The goal of the review is to maximize shareholder value and better position the Company for long-term stability and growth.Given the Company's decision to initiate this strategic review, alongside the historic volatil
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - February 1, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") is pleased to announce that, in accordance with its current monthly dividend policy, the Board of Directors of the Company has declared a dividend of US$0.0315 per subordinate voting share for the month of February 2023. Simultaneously with declaring the dividend on the subordinate voting shares, the directors also declared a dividend on the Company's multiple voting shares equal to US$3.15 per share and a dividend on the Company's proportionate voting shares equal to US$0.0315 per share.The dividend is pa
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - June 21, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that its Board of Directors unanimously voted to conclude its previously announced asset sale process, which was being conducted by Stephens Inc. ("Stephens").Beginning on March 8, 2023, Stephens broadly solicited expressions of interest in a sale of various strategic, highly productive assets recently developed and proven by the Company. After considering several bids, the Company's Board of Directors concluded that the bids were not reflective of the value of the underlying assets and it wa
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - May 31, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that it issued 19,494,709 Class A subordinate voting shares ("Subordinate Voting Shares") of the Company upon the redemption (the "Redemption") by a majority of the holders of Class B non-voting units of ("Units") of HB2 Origination, LLC ("Origination"), a subsidiary of Alpine Summit. An additional 15,947 Subordinate Voting Shares were issued in connection with the mandatory conversion of the outstanding Class C proportionate voting shares ("Proportionate Voting Shares") as a result of the Rede
Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that shareholders approved all proposals put forth at the Company's Annual General Meeting of Shareholders (the "Meeting") held on May 25, 2023, including the re-election of all five directors of the Company, amendments to the Company's Deferred Share Unit Plan, and the reappointment of Weaver and Tidwell, LLP, as the independent registered public accounting firm of the Company. Detailed results of the proposals considered at the Meeting are disclosed in the Report of Voting Results filed under
Gainers PainReform Ltd. (NASDAQ:PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 22.8% to $0.1255 after the FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test. SigmaTron International, Inc. (NASDAQ:SGMA) shares climbed 25.3% to $4.4861 after the company reported results for the fourth quarter. Pasithea Therapeutics Corp. (NASDAQ:KTTA) gained 21% to $0.5790 after the company rejected an unsolicited, non-binding acquisition proposal from Lucy Scientific Discovery. The company
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday. PainReform Ltd. (NASDAQ:PRFX) shares gained 31.8% to $9.37 in pre-market trading after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. Dynatronics Corporation (NASDAQ:DYNT) rose 17.3% to $0.9170 in pre-market trading. BRF S.A. (NYSE:BRFS) gained 8.4% to $2.07 in pre-market trading after gaining around 4% on Wednesday. Ault Alliance, Inc. (NYSE:AULT) shares rose 8% to $4.06 in pre-market trading after falling 8% on Wednesday. Cosmos Health Inc. (NASDAQ:COSM) shares gained 7
Gainers Prestige Wealth Inc. (NASDAQ:PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per share. Gorilla Technology Group Inc. (NASDAQ:GRRR) jumped 68.9% to $3.52 after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution. Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares climbed 64.8% to $0.3576 after dropping over 5% on Thursday. Castle Biosciences, Inc. (NASDAQ:CSTL) shares surged 42.2% to $18.89. Castle Biosciences will present new DecisionDx-SCC and DecisionDx-melanoma data at the American Head